## LRCX: Lam Research Corporation - XLK: Technology

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.8% in lower entry zone (4.0-10.0%), top 5% cross-sectional ranking. Short-term MRS_5 (2.4%) confirms momentum alignment. Strong momentum (+6.1% 5-day acceleration). Outperforming sector by 6.6%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($161.28)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 7, Bearish: 0)

**1. Brokers Suggest Investing in Lam Research (LRCX): Read This Before Placing a Bet**
- Source: Finviz | 20251222T160911 | Somewhat-Bullish | Relevance: 100%
- This article analyzes brokerage recommendations for Lam Research (LRCX), which currently holds an average brokerage recommendation (ABR) of 1.69, indicating a strong buy to buy. However, it cautions against relying solely on ABRs due to potential analyst bias and instead suggests using the Zacks Rank, a proprietary stock rating tool, for more reliable investment decisions. Lam Research currently has a Zacks Rank #2 (Buy), supported by growing optimism among analysts regarding its earnings prospects.

**2. Lam Research Hits 52-Week High: Is the Stock Still Worth Buying?**
- Source: The Globe and Mail | 20251222T141106 | Bullish | Relevance: 100%
- Lam Research (LRCX) recently hit a 52-week high, driven by the AI boom and strong demand for its wafer fabrication equipment. The company's financial performance, supported by growth in AI and advanced packaging, remains impressive despite macroeconomic challenges. Analysts anticipate continued revenue and EPS growth, and the stock is considered reasonably priced, making it a compelling investment option.

**3. Legacy Wealth Asset Management LLC Purchases 8,270 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251222T114858 | Bullish | Relevance: 100%
- Legacy Wealth Asset Management LLC increased its stake in Lam Research Corporation by 62.5%, adding 8,270 shares to hold a total of 21,512 shares valued at $2.88 million. This makes Lam Research the 17th largest position in their portfolio, representing approximately 0.7% of their total investments. The semiconductor company recently reported strong earnings, exceeding analyst expectations with $1.26 EPS and $5.32 billion in revenue, and has received multiple price target upgrades from analysts, resulting in a "Moderate Buy" consensus rating.

**4. Lam Research (LRCX) Stock: Key News, Analyst Forecasts, and What to Watch Before the Dec. 22, 2025 Market Open**
- Source: ts2.tech | 20251222T020851 | Bullish | Relevance: 100%
- Lam Research (NASDAQ: LRCX) heads into the December 22, 2025 market open with significant momentum, driven by analyst upgrades, increasing optimism for AI-driven semiconductor capital spending, and improving sentiment in the memory supply chain. The article details the factors contributing to the stock's rally, including rising wafer fab equipment spending forecasts and Lam's crucial exposure to memory manufacturing. Investors should monitor ongoing analyst forecasts and the potential impact of U.S.-China export controls during the holiday-shortened trading week.

**5. Flputnam Investment Management Co. Buys 25,173 Shares of Lam Research Corporation $LRCX**
- Source: MarketBeat | 20251221T114703 | Bullish | Relevance: 100%
- Flputnam Investment Management Co. increased its stake in Lam Research Corporation by 5.3%, purchasing an additional 25,173 shares and now holding 496,854 shares valued at $66.53 million. This makes Lam Research the 17th largest position in Flputnam's portfolio, representing 1.0% of their total holdings. The increase in holdings aligns with a positive sentiment from several sell-side firms, which have raised price targets for LRCX and maintained buy/outperform ratings, coupled with the company's strong Q3 earnings beat and positive Q2 2026 guidance.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-23 | UBS | $200 | $175 | +14% |
| 2025-12-18 | B. Riley Securi | $195 | $180 | +8% |
| 2025-12-17 | Mizuho | $200 | $170 | +18% |
| 2025-12-15 | Jefferies | $200 | $175 | +14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-23 | UBS | main | Buy |
| 2025-12-18 | B. Riley Securi | main | Buy |
| 2025-12-17 | Mizuho | main | Outperform |
| 2025-12-15 | Jefferies | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 12 ($2.00M) |
| Sells | 6 ($14.54M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+0.3%)
- Blackrock Inc.: 9.9% (+1.7%)
- JPMORGAN CHASE & CO: 4.8% (+47.4%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 2.7% (-0.5%)

### Key Risks

1. Heavy insider selling: $15M sold (6 transactions in 90 days).
2. Market regime shift could impact high-beta names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 6 raises (avg +13%) could attract flows.
- Momentum building: MRS_20 improving +6.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.04 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 62%, ROA 20%, margin 30%). Balance sheet: strong liquidity (2.2x), $1.6B free cash flow. Analyst sentiment positive (6 raises, avg +13%). Insider selling cluster ($14.5M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $220.9B |
| Beta | 1.78 |
| 52W Range | $56.32 - $177.29 |
| Short Interest | 3.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.04 |
| Forward P/E | 31.1 |
| Current P/E | 36.2 |
| YoY Growth | 16.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from 0.8% to 6.8% (+6.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 95th percentile. MRS_5 at 2.4% confirms short-term momentum alignment. AM_20 at 7.9% shows strong absolute momentum above own 20MA. Outperforming sector by 6.6pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.08), confirming momentum. Elevated volume (1.7x 20MA), institutional activity likely. OFD pattern: -DUL (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.85% (CS: 95) | Strong |
| RSI_14 | 63.4 | Neutral |
| MACD Histogram | 1.08 | Bullish |
| vs SMA20 | 1.079x | Above |
| vs SMA50 | 1.123x | Above |
| vs SMA200 | 1.599x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $175.16
- **Stop Loss:** $161.28 (7.9% risk)
- **Target:** $195.98 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 86
- **Position Value:** $15,063.76
- **Portfolio %:** 15.06%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite in holiday-thinned conditions. VIX at 52-week lows suggests complacency, but modest breadth improvement and stable yields indicate underlying stability. Focus on quality positioning ahead of 2026 catalysts.*

### Earnings

**Next:** 2026-01-28 (Est: $1.16)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.22 | $1.26 | +3.3% |
| 2025Q2 | $1.21 | $1.33 | +10.4% |
| 2025Q1 | $1.00 | $1.04 | +4.1% |
| 2024Q4 | $0.88 | $0.91 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*